For the Quarter Ending March 2026
Prednisolone Prices in North America
- In United States, the Prednisolone Price Index rose quarter-over-quarter in Q1 2026, driven by elevated input costs.
- The Prednisolone Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0%.
- The Prednisolone Demand Outlook strengthened in March 2026, supported by a 4.0% increase in retail sales.
- The Prednisolone Price Forecast indicated upward momentum in March 2026, influenced by a 3.3% CPI rise.
- The Manufacturing Index expanded in March 2026, which supported steady Prednisolone formulation and robust sector activity.
- Industrial production grew 0.7% in March 2026, which constrained bulk pharmaceutical output and prevented market oversupply.
- A stable 4.3% unemployment rate in March 2026 ensured patient access and sustained prescription Prednisolone consumption.
- Consumer confidence reached 91.8 in March 2026, which maintained steady outpatient demand for dermatological Prednisolone creams.
- Domestic soybean oil feedstock demand for industrial use strengthened in January 2026, impacting Prednisolone precursor availability.
Why did the price of Prednisolone change in March 2026 in North America?
- Soybean oil extraction rates declined in January 2026, which increased overall Prednisolone precursor processing costs.
- United States soybean oil exports strengthened in January 2026, which shifted global feedstock trade flows.
- Diesel producers reduced soybean oil consumption in January 2026, which altered energy sector feedstock competition.
Prednisolone Prices in APAC
- In China, the Prednisolone Price Index rose quarter-over-quarter in Q1 2026, driven by rising factory-gate prices.
- The Prednisolone Production Cost Trend increased in March 2026 as the Producer Price Index rose 0.5%.
- The Prednisolone Demand Outlook strengthened during Q1 2026 because pharmaceutical API outsourcing production scale surged.
- The Prednisolone Price Forecast reflected upward momentum in March 2026 due to surging API demand.
- The Manufacturing Index expanded in March 2026, reflecting higher production volumes in the pharmaceutical sector.
- Industrial production grew 5.7% in March 2026, ensuring steady availability of precursors for Prednisolone synthesis.
- Consumer prices rose 1.0% in March 2026, indicating stable purchasing power for pharmaceutical formulations.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, softening discretionary healthcare demand.
- Consumer confidence stood at 91.6 in February 2026, causing patients to delay mild inflammatory treatments.
Why did the price of Prednisolone change in March 2026 in APAC?
- Prednisolone prices rose in Q1 2026 due to increased production costs from rising factory-gate prices.
- Surging pharmaceutical API outsourcing demand in Q1 2026 supported higher downstream consumption for corticosteroid derivatives.
- Phytosterol precursor feedstock costs fluctuated during Q1 2026 amid shifting agricultural processing dynamics in China.
Prednisolone Prices in Europe
- In Germany, the Prednisolone Price Index rose quarter-over-quarter in Q1 2026, primarily driven by surging naphtha feedstock costs.
- The 2.7% Consumer Price Index increase in March 2026 elevated the Prednisolone Production Cost Trend for synthesis.
- Conversely, the Producer Price Index declined by 0.2% in March 2026, reflecting an easing Prednisolone Price Index.
- The Manufacturing Index expanded in March 2026, demonstrating recovering industrial activity and a positive Prednisolone Demand Outlook.
- Industrial production remained stagnant at 0.0% in February 2026, reflecting flat baseline activity in bulk pharmaceutical manufacturing.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, sustaining steady consumer Prednisolone demand.
- Consumer confidence dropped to -24.7 in March 2026, negatively impacting peripheral and veterinary Prednisolone demand applications.
- Chemical precursor inventories tightened severely in March 2026, driving an upward Prednisolone Price Forecast amid supply disruptions.
Why did the price of Prednisolone change in March 2026 in Europe?
- Naphtha feedstock and energy costs surged significantly during Q1 2026 due to Middle East disruptions.
- Regional chemical precursor inventories tightened severely in March 2026 following multiple producer force majeure declarations.
- Robust domestic demand for German pharmaceutical consumer and intermediate goods strengthened noticeably during January 2026.
For the Quarter Ending December 2025
Prednisolone Prices in North America
- In the United States, the Prednisolone Price Index rose quarter-over-quarter in Q4 2025, driven by robust demand and rising costs.
- Prednisolone production costs increased due to a 2.7% year-over-year CPI rise in December 2025, impacting raw materials.
- Input costs for Prednisolone API manufacturers climbed, with PPI increasing 3.0% year-over-year in November 2025.
- Prednisolone demand outlook strengthened, supported by a 2.0% year-over-year industrial production increase in December 2025.
- Consumer spending, indicated by a 3.3% year-over-year retail sales increase in November 2025, bolstered Prednisolone demand.
- Energy costs for Prednisolone production were mixed; natural gas prices softened in December 2025, electricity revenues increased in November 2025.
- The pharmaceutical market outperformed in Q4 2025, alongside dynamic life sciences activity, supporting Prednisolone demand.
- US imports of pharmaceutical preparations declined in October 2025, influencing domestic Prednisolone supply and pricing.
Why did the price of Prednisolone change in December 2025 in North America?
- Rising input costs, including a 3.0% year-over-year PPI increase in November 2025, pressured Prednisolone prices upward.
- Robust consumer spending, with retail sales up 3.3% year-over-year in November 2025, boosted Prednisolone demand.
- Increased healthcare spending in FY 2025 and a strong pharmaceutical market in Q4 2025 supported Prednisolone price increases.
Prednisolone Prices in APAC
- In China, the Prednisolone Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices.
- Prednisolone production costs decreased in December 2025, as the Producer Price Index declined by 1.9% year-over-year.
- Demand for pharmaceutical raw materials in China experienced growth throughout 2025, supporting Prednisolone demand.
- The Prednisolone Price Forecast suggests stability due to weak inflationary pressures, with CPI at 0.8% year-over-year in December 2025.
- China's Manufacturing Index expanded in December 2025, indicating a robust industrial environment for Prednisolone supply.
- Industrial production rose by 5.2% year-over-year in December 2025, ensuring stable supply chains for Prednisolone manufacturing.
- Volatile coal and solvent prices exerted pressure on small Prednisolone producers in China throughout 2025.
- China's medicine exports, including active pharmaceutical ingredients, steadily increased in the first 11 months of 2025.
- Subdued domestic consumer demand was evident as retail sales grew only 0.9% year-over-year in December 2025.
Why did the price of Prednisolone change in December 2025 in APAC?
- Producer prices declined by 1.9% year-over-year in December 2025, reducing Prednisolone manufacturing costs.
- Weak consumer spending, with retail sales up only 0.9% year-over-year in December 2025, dampened domestic demand.
- Strong medicine export growth in the first 11 months of 2025 partially offset domestic demand weakness.
Prednisolone Prices in Europe
- In Germany, the Prednisolone Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices.
- Prednisolone production costs remained high in October 2025, with carbon costs rising during 2025.
- However, producer prices declined 2.5% year-over-year in December 2025, reducing manufacturing input costs.
- Healthcare market demand for Prednisolone remained stable in Q4 2025, supported by demographic tailwinds and 1.1% retail sales growth.
- Moderate inflation, with CPI at 1.8% in December 2025, contributed to general operating costs for manufacturers.
- The Manufacturing Index was contracting in December 2025, indicating a slowdown in economic activity and plummeting order backlogs in October.
- German industrial production inched up 0.8% year-over-year in October 2025, despite 6.2% unemployment in December 2025.
- Consumer confidence was significantly pessimistic at -17.5 in December 2025, dampening overall market sentiment.
Why did the price of Prednisolone change in December 2025 in Europe?
- Producer prices declined 2.5% year-over-year in December 2025, reducing manufacturing costs.
- The Manufacturing Index was contracting in December 2025, signaling weaker industrial activity.
- High unemployment at 6.2% and low consumer confidence in December 2025 dampened demand.
For the Quarter Ending September 2025
North America
- In United States, the Prednisolone Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs.
- Prednisolone production costs increased, with the Producer Price Index rising 2.6% year-over-year in August 2025.
- Broader inflationary pressures, indicated by a 3.0% CPI increase in September 2025, impacted operational expenses.
- Energy costs for manufacturing rose; industrial electricity increased in August 2025, natural gas prices in Q3 2025.
- Industrial production grew modestly by 0.1% year-over-year in September 2025, indicating a stable manufacturing backdrop.
- Robust consumer spending, with retail sales up 5.42% year-over-year in September 2025, supported Prednisolone demand.
- A low unemployment rate of 4.3% in September 2025 bolstered consumer access to healthcare and prescriptions.
- US biotech and pharmaceutical sectors experienced an upward trajectory in Q3 2025, signaling positive market sentiment.
Why did the price of Prednisolone change in September 2025 in North America?
- Rising Producer Price Index (2.6% in August 2025) directly increased Prednisolone manufacturing costs.
- Industrial electricity costs rose in August 2025, and natural gas prices increased in Q3 2025.
- Robust retail sales (5.42% in September 2025) and low unemployment (4.3%) supported demand.
Europe
- In Germany, the Prednisolone Price Index rose quarter-over-quarter in Q3 2025, driven by elevated production costs.
- Despite a 1.7% decline in the Producer Price Index in September 2025, Prednisolone production costs increased from specific input factors.
- Wholesale electricity and natural gas prices faced upward pressure in Q3 2025, significantly impacting manufacturing expenses.
- German industrial production declined 1.0% year-over-year in September 2025, signaling potential supply chain disruptions.
- The Manufacturing Index was contracting in Q3 2025, indicating a broader industrial slowdown affecting chemical supply.
- Consumer Price Index rose 2.4% year-over-year in September 2025, contributing to general inflationary pressures on operational costs.
- Prednisolone demand showed moderate growth in Q3 2025, supported by an aging population and firming pharmaceutical output.
- Retail sales increased 0.2% year-over-year in September 2025, offering mild support to overall economic stability.
- The unemployment rate remained stable at 6.3% in September 2025, suggesting economic headwinds for healthcare affordability.
Why did the price of Prednisolone change in September 2025 in Europe?
- Elevated raw material costs, coupled with increased wholesale electricity and natural gas prices in Q3 2025, significantly raised production expenses.
- A contracting Manufacturing Index and 1.0% decline in industrial production in September 2025 constrained Prednisolone supply.
- The Consumer Price Index rising 2.4% in September 2025 indicated broader inflationary pressures on operational costs.
APAC
- In China, Prednisolone Price Index fell in Q3 2025, influenced by declining producer prices and soft consumption.
- Prednisolone production costs faced downward pressure as Producer Price Index declined 2.3% year-over-year in September 2025.
- Key raw material prices for the broader manufacturing sector increased in August 2025, impacting pharmaceutical intermediate costs.
- Prednisolone demand outlook remained soft in Q3 2025, with unemployment at 5.2% and consumer confidence at 89.6 in September 2025.
- Consumer Price Index declined 0.3% year-over-year in September 2025, reflecting weak consumer demand.
- China's Manufacturing Index was contracting in September 2025, indicating industrial activity slowdown.
- Industrial production expanded 6.5% year-over-year in September 2025, supporting Prednisolone supply capacity.
- Raw material inventories tightened July-August 2025, potentially supporting Prednisolone supply dynamics.
- China's total goods exports surged in September 2025, suggesting external demand strength for manufactured goods.
Why did the price of Prednisolone change in September 2025 in APAC?
- Producer Price Index declined 2.3% in September 2025, reducing Prednisolone production costs.
- Soft domestic consumption, with CPI down 0.3% in September 2025, dampened demand.
- Contracting Manufacturing Index in September 2025 signaled industrial slowdown, impacting supply efficiency.
